Tagged with HAI

Thailand Anutin Charnvirakul, recently appointed deputy prime minister and minister of public health of Thailand, shares his initial priorities since taking on the role in July 2019. Charnvirakul then goes on to cover the most significant topics impacting Thailand’s healthcare ecosystem such as the legalization of medical cannabis, the country’s Thailand…

Thailand As Thailand’s focus has shifted towards R&D over the past few years, the number of in-country clinical trials being conducted has increased concurrently. From 2011 to 2016, Thailand conducted a total of 739 clinical trials, the largest number within the Southeast Asian region, followed by Singapore (610 trials) and Malaysia…

Thailand Suchart Chookruvong and Wanna Thanesanont of Thai generics player Polipharm, highlight the growing importance of R&D within their strategy, how the firm has remained focused on quality, and why Polipharm aims to position itself as the partner of choice for all stakeholders in Thailand; a local company with an international…

Thailand Riaz Buksh, general manager of Bayer’s Pharmaceuticals Division in Thailand, Cambodia, Myanmar, and Laos, highlights the importance of the mission “Science for a Better Life” and innovation in the affiliate, as well as the vision of Bayer in driving transformative partnerships with government and medical stakeholders.   A collaboration of…

Thailand Kevin Peters, Managing Director of MSD in Thailand, highlights the strategic significance and strong performance of the affiliate as a top three pharmaceutical player in Thailand. Kevin goes on to share his mission to position MSD as an innovative partner of Thailand’s healthcare stakeholders in improving the outcomes, access, and…

Thailand Kris Sisneros, managing director of Merck Thailand highlights the importance of going beyond therapeutic areas and caring about the Thai people, the patient and the people in the company. He offers insights into the strength of Merck Thailand within the Thai health ecosystem.   Every year in Thailand we treat…

Thailand Thailand is known around the world for its lush landscapes, ancient architecture and breathtaking beaches. The nation receives more than 35 million visitors each year. Thailand ranked 4th globally for adventure value and 7th for cultural heritage in US News’ 2017 Best Countries Report, and Bangkok consistently ranks among the…

Thailand Thailand was the world’s fourth-largest medical tourism destination in 2017, with a market value of around USD 600 million. Made with Visme Infographic Maker  

Thailand Thailand’s medical devices (medtech) market is projected to grow from USD 1.2 billion in 2016 to 1.7 billion in 2020, representing a CAGR of 8.1%. Made with Visme Infographic Maker  

Thailand The Thai pharma market, one of the largest in the ASEAN region, stood at USD 4.6 billion in size in 2016. A recent report from the Dutch Embassy in Thailand projects that the market will grow to USD 6.3 billion in 2021 and 8.4 billion by 2026. Made with Visme…

Thailand Thailand’s healthcare expenditure is projected to rise from USD 25.3 billion in 2016 to 47.9 billion by 2026, a ten-year CAGR of 6.6%.  Made with Visme Infographic Maker   According to a 2018 report from the Dutch Embassy in Thailand, in 2018 Thailand had around 50,000 physicians and 25,000 health…

Thailand Suthep Namwongsamran, GM of M&H Manufacturing, provides insights into the distinctive model that has allowed M&H to become one of Thailand’s leading domestic pharmaceutical manufacturers. He also outlines the expected development of the M&H’s international strategy and his focus on bringing biosimilars to Thailand via mutually beneficial partnerships.   We…